在生物传感和生物试验中增强酶模拟物的基质选择性:新的方法
Amir M Ashrafi1, Atripan Mukherjee2, Arezoo Saadati3
1Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Institute of Photonics and Electronics, Czech Academy of Sciences, Prague, Czech Republic.
Advances in colloid and interface science
|June 26, 2024
概括
人工酶为天然酶提供了强大的,具有成本效益的替代品,但缺乏基质选择性. 本综述探讨了提高分子印记聚合物,纳米酶 (NZ) 和DNA酶选择性的策略,以改善生物感知应用.
科学领域:
- 生物模拟化学是生物模拟化学.
- 纳米技术纳米技术
- 催化剂是一种催化剂.
背景情况:
- 纳米级材料提供类似酶的催化活性,具有稳定性,可扩展性和可修改性的优势.
- 人工酶的一个关键限制是,与天然酶相比,它们的基质选择性很差.
研究的目的:
- 为了解决人工酶中的基质选择性挑战.
- 审查提高分子印记聚合物,纳米酶 (NZs) 和DNA酶的基质选择性的策略.
- 讨论酶模拟剂在生物传感和生物测试中的应用机制.
主要方法:
- 对人工酶的基质选择性策略的文献综述.
- 对分子印记聚合物,纳米酶和DNA酶的策略的分类.
- 在生物传感和生物测试应用中分析功能机制.
主要成果:
- 鉴定并举例说明了人工酶的各种基质选择性策略.
- 通过合理设计证明了增强的基质选择性.
- 概述了生物感知中的酶模仿剂的功能机制.
结论:
- 基质选择性策略显著提高了人造酶的性能.
- 需要进一步的研究来提高生物传感的选择性和方便性.
- 未来的工作应该集中在效率和仿生学的实际应用上.
相关概念视频
Enzymes
81.4K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.4K
Introduction to Mechanisms of Enzyme Catalysis
8.1K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
8.1K
Enzyme-Linked Immunosorbent Assay
12.7K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
12.7K


